ADS makes ‘strides’ toward improving diabetes management

Updated 9:19 AM CDT, Fri September 6, 2024

CARLSBAD, Calif. – With the growth in Type 2 diabetes and the expansion of coverage for continuous glucose monitors by both Medicare and other payers, Advanced Diabetes Supply’s new StrideForward program can fill a potential gap in care, says CEO Bill Mixon.

The program, which is offered in partnership with StrideMD and which is billable to insurance, will offer select ADS members with Type 2 diabetes access to a full suite of remote patient monitoring and virtual care support services from a team of endocrinologists, certified diabetes educators and other medical professionals.

“More of these patients are being prescribed CGM in the primary care physician’s office and we all know how challenging it is for a PCP’s office to keep up with all of their patients,” Mixon said. “That’s perhaps even more critical with people living with diabetes whose primary care is a PCP. In between those doctor visits, this is a productive and timely intervention that can happen on behalf of the patient to help them monitor their and manage and enhance outcomes.”

The StrideForward platform, will also offer real time glucose readings and data aggregation to offer users insights into actions they can take, such as medication adjustments, to improve outcomes. Prescribers can view the data, too.

In addition to improved care, access to specialty care programs such as StrideForward can save $4,000 per patient annually over three years, says Mixon.

“Diabetes management requires a comprehensive approach that includes medication and lifestyle adjustments, as well as access to reliable medical supplies,” he said. “(Improving outcomes) can reduce costs for the health care system. Those are a lot of really good things and it’s why we’re excited about the program.”

The initial program launch is for 12 months, with plans to expand in 2025, says Mixon.

“We’re very focused on enabling a healthier and more fulfilling life for people living with diabetes and you know that’s what we’re all about and that’s what we want to do,” he said.